Aurélie Barrail-Tran

8PUBLICATIONS
26CO-AUTHORS
Disease surveillanceBehavioural epidemiologyPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 27, 2026
HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir.

Gilbert Mchantaf, Adeline Melard, Kévin Da Silva

|Aug 01, 2024
Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates.

Thibaut Gelé, Hélène Gouget, Nastasia Dimant

|Jan 11, 2024
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.

Caroline Passaes, Delphine Desjardins, Anaïs Chapel

|Apr 26, 2023
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records.

Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette

|Nov 11, 2022
Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates.

Thibaut Gelé, Hélène Gouget, Nathalie Dereuddre-Bosquet

Pageof 2